Objectives: The aim of this study was to evaluate the efficacy on crying episodes owing to infantile colic of a new infant formula containing partially hydrolysed whey proteins, prebiotic oligosaccharides (OS), with a high b-palmitic acid content. Design: Prospective randomized controlled study. Setting: Italy. Subjects: Two hundred and sixty-seven formula-fed infants, aged less than 4 months, with infantile colic, were randomized to receive either the new infant formula (study treatment (ST)) or a standard formula and simethicone (6 mg/kg twice a day) (control treatment (CT)). A questionnaire was given to parents to evaluate for 14 days the daily number of colic episodes and crying time. Results: Out of the 199 infants who completed the study, 96 were treated with the new formula and 103 were not treated. Infants receiving the new formula had a significant decrease in colic episodes after 1 week (2.4771.94 at day 7 vs 5.9971.84 at the study entry) compared to infants receiving the CT (3.7271.98 at day 7 vs 5.4171.88 at the study entry) (Po0.0001). Also at day 14, the crying episodes were significantly different between the two groups of infants (1.7671.60 in ST vs 3.3272.06 in CT) (Po0.0001). Conclusions: The use of a partially hydrolysed formula supplemented with fructo-and galacto-OS induces a reduction of crying episodes in infants with colic after 7 and 14 days when compared with a standard formula and simethicone.
Introduction
Infantile colic is a very common problem in infancy. Although it is frequently reported and despite 40 years of research, its aetiology still remains unclear and its treatment is often ineffective and difficult.
There is increased evidence that this symptom is related to food allergy and sometimes it is the first clinical manifestation of atopic disease (i.e. allergy to cow's milk protein), but the strength of the relationship is not well defined (Hill and Hosking, 2000; Kalliomäki et al., 2001; Sicherer, 2003) . Hypoallergenic formulas and mainly extensively hydrolysed formulas are effective in the treatment of infantile colic, indicating that dietary factors can play an important role (Lindberg, 1999; Jakobsson et al., 2000; Lucassen et al., 2000) . However, considering the favourable clinical course of infantile colic, the wide range of manifestations, the day to day variability of crying time and the fact that many but not all the affected infants have symptoms related to cow's milk allergy, the majority of the studies on dietary interventions, particularly in formula-fed infants, concluded that further research is necessary (Lucassen et al., 1998; Garrison and Christakis, 2000) .
Some differences in gut microflora have been shown also in colicky infants (Lehtonen et al., 1994; Savino et al., 2004) . Recently, we have evaluated intestinal lactobacilli species in breast-fed infants with infantile colic, finding that Lactobacillus brevis and Lactobacillus lactis lactis might be involved in the pathogenesis of this problem increasing meteorism and abdominal distension (Savino et al., 2005) .
These findings suggest that the modulation of gut microflora might help the prevention of common gastrointestinal symptoms such as constipation, fussing and prolonged colicky crying, particularly in formula-fed infants, who have well-known differences in intestinal microbiota compared to breast-fed ones .
Multiple reports in literature have shown that oligosaccharide (OS) supplementation in infant formulas may promote gastrointestinal health. Although potential benefits have been recently underlined by many authors (Rigo et al., 2001; Boehm et al., 2003; Schmelzle et al., 2003; , the ESPGHAN Committee of Nutrition has concluded that there are only limited published data about prebiotics in dietetic products for infants and that well-designed randomized controlled trials are requested to validate clinical outcome measures of prebiotic effects in infants (Agostoni et al., 2004) .
A new formula has been specifically developed in order to simulate the beneficial effects of human milk and to reduce some of the common feeding problems of formula-fed infants. This formula contains partially hydrolysed whey proteins, a mixture of OS 0.8 g/100 ml, comprising 90% galacto-OS (GOS) and 10% fructo-OS (FOS), low lactose level, modified vegetable oil with 41% of the palmitic acid in the b-position and starch.
In a previous observational study, within 2 weeks of feeding with this new formula, a significant decrease in the number of colic episodes per day was observed in the majority of infants followed for minor gastrointestinal symptoms (Savino et al., 2003) .
Our study was performed to confirm the role of this new formula in colicky infants with a randomized prospective controlled trial.
Materials and methods

Subjects
All the formula-fed infants aged less than 4 months and affected by infantile colic were candidates for study inclusion.
The subjects were recruited in Italy from 78 general paediatricians and at the Department of Paediatrics of the University of Turin, between August 2002 and January 2003.
The inclusion criteria were gestational age between 37 and 42 weeks, normal birth weight (42500 g), regular weight gain (X150 g/week) and normal physical examination.
Infants with any of the following characteristics were excluded from the study: neonatal problems, assumption of any kind of medication during the week before the beginning of the study and during the study period.
Colic was diagnosed when infants had at least three episodes of unexplained full-forced crying lasting more than 3 h a day on at least 3 days a week, according to Wessel criteria (Wessel et al., 1954) . Crying episodes were considered significant and recorded by parents when they endured more than 40 min.
Study design
As regards the efficacy on infantile colic, the primary end point of this study was the reduction of the number of fullforced inconsolable crying episodes lasting more than 40 min, so that the overall crying time endured less than 3 h a day, which is the cutoff proposed by Wessel's (Wessel et al., 1954) .
The day when the paediatricians saw the infants for the first time was defined as day 1. On this occasion, the consulting paediatrician told the parents that the study had two different treatments: one based on the new formula (study treatment (ST)) and the other based on a standard formula and simethicone (6 mg/kg twice a day) (control treatment (CT)). Each paediatrician received two different numbered folders: the first with yellow questionnaires corresponding to the study group, the other with blue questionnaires for the control group. In the pre-executive phase of the study, random numbers were generated; they were printed on the first page of the questionnaires and put in closed envelopes. Each paediatrician was randomly assigned to start either the ST or the CT. If parents answered 'Yes' to the participation to the study, their infant was assigned to one of these groups by random allocation.
Simethicone was used in the CT because it is as effective as placebo in the treatment of infantile colic (Lucassen et al., 1998; Garrison and Christakis, 2000) . The composition of the formulas used in the study is given in Table 1a ; molecular weight percentage distribution of partially hydrolysed proteins in the new formula is reported in Table 1b .
A detailed report of gastrointestinal problems, family history for atopy as well as feeding practice was recorded for each infant. A questionnaire was given to the parents to monitor symptoms frequency and feeding volume. On days 1, 7 and 14, paediatricians examined all the infants. The feeding volume was based on a feeding ad libitum procedure. Feeding frequency was decided by parents and was not influenced by the study protocol; the number of significant colic episodes was daily recorded by parents.
Parents gave their consent to the inclusion of their infants in the study. The Ethical Committee of our Institution approved the study protocol and infants were enrolled in the study only after written informed consent was obtained from their parents. A specific question about the insurance that the tested formulas were the only ones being used and that no other food or medication was administered to the infants was written at the end of the questionnaire.
Statistical analysis
With a significance level of 0.05 and a power of 0.90, it was calculated that a recruitment of 80 infants in each group was necessary to observe a significant decrease of at least one colic episode in the study group. 
Results
Out of the 267 infants who presented the symptom 'colic' between August 2002 and January 2003, 130 were randomly assigned to the treatment with the new formula (ST) and 137 to a standard formula and simethicone (CT). After a second revision, 45 of them did not satisfy the inclusion criteria (20 in the ST; 25 in the CT) having consumed other foods or medications than the tested treatments. Adherence to the treatment was of 81.7% in the CT and 84.6% in the ST. The remaining 222 infants constituted the study population; out of these subjects, 14 of the ST and nine of the CT were excluded from follow-up because at day 7 they had too many missing data. In this way, a total of 68 infants were excluded from the final analysis ( Figure 1) . Out of the 199 infants who completed the study, 103 were treated with the CT (51.8%) and 96 were treated with the ST (48.2%). No significant difference for age and gender at the enrolment was observed, nor for family history for atopy (ST vs CT ¼ 32% vs 27%; P ¼ 0.43) ( Table 2 ). The subjects were not significantly different for the number of colic episodes at entry (ST vs CT ¼ 5.9971.84 vs 5.4171.88; P ¼ 0.290; confidence interval (CI) 95%: À0.24, 0.80) ( Table 2 ). On days 7 and 14, CT infants had a higher number of colic episodes than ST ones: 3.7271.98 (CT) vs 2.4771.94 (ST) (Po0.0001; CI 95%: À0.7, À1.8) at day 7 and 3.3272.06 (CT) vs 1.7671.60 (ST) (Po0.0001; CI 95%: À1.0, À2.1) at day 14 ( Table 2) . The difference in the number of colic episodes between ST and CT estimated on 91 pairs at days 7 and 14 using a multivariate model, adjusted for gender, age at the entry, maternal instruction, parity, birth weight, number of feedings/day and kind of stool at the entry, was À1.45 colic on day 7 (Po0.0001; CI 95%: À0.99, À1.92) and À1.78 on day 14 (Po0.0001; CI 95%: À1.31, À2.25) ( Table 3) .
Discussion
In this controlled study, we provided a new dietary approach to reduce crying episodes owing to infantile colic in formulafed infants.
Our findings show that infants fed with a partially hydrolysed formula, added with a mixture comprising 90% GOS and 10% FOS, had a significant decrease in colic episodes after 1 week of treatment compared to infants from the control group, confirming data of a previous observational study (Savino et al., 2003) and according to most of the diet studies on infantile colic (Lucassen et al., 1998 (Lucassen et al., , 2000 Garrison and Christakis, 2000) . The difference in crying time was even more significant after 2 weeks of treatment.
In many cases, dietary modifications could appear more suitable than pharmacological treatment in resolving 
. Energy content of NF becomes 71.5 kcal/100 ml if energy content of GOS/FOS is assumed to be 1.9 kcal/g.
Table 1b
Molecular weight percentage distribution of partially hydrolysed proteins in the study formula
Molecular weight distribution (kDa ¼ kiloDalton)
420 20-10 10-5 5-2 2-1 o1
Omneo (Numico) (%) o1.0 o1.0 1.6 9.2 19.8 68.1
Randomized controlled study for infantile colic F Savino et al symptoms (Miller-Loncar et al., 2004) : Lucassen, in a recent review, reported that infantile colic should be treated preferably with a 1-week trial of a hypoallergenic formula (Lucassen et al., 1998) . On the other hand, as Garrison suggested the need of further studies on existing and alternative dietary therapies (Garrison and Christakis, 2000) , our study could represent a first step approaching colic from changing the feeding formula.
The underlying mechanism accounting for the reduction of colic episodes is not completely known, but it is likely that this could be influenced not only by a downregulation of allergic response but also by beneficial effects of other factors on bowel digestive functions.
Partially hydrolysed bovine proteins can accelerate gastrointestinal transit-time via reduction of opioid activity released during digestion, as recently reported in an experimental study by Mihatsch et al. (2005) .
In contrast, palmitic acid in the first and third position, which is the predominant structure found in cow milk and infant formulas, may form calcium-fatty acid complexes, which are poorly absorbed in the gut. The lipid fraction of the formula we have tested, containing palmitic acid in the b-position of the triglyceride molecule in a higher amount (41%) than in normally used vegetable lipids, should significantly reduce the build-up of calcium soaps in the gut. This should improve bowel habit in formula-fed colicky infants. Moreover, not only the steric distribution of fatty acids and carbohydrates lead to more physiological metabolism of nutrients and improve gut omeostasis but also the OS content seems to have a human milk-similar effect in growth Randomized controlled study for infantile colic F Savino et al promotion of beneficial intestinal flora (Lucas et al., 1997; Boehm et al., 2004; Knol et al., 2005) . Growing evidence underlines that common gut disorders in infancy (including infantile colic, meterorism, flatulence, food intolerance and allergy) can also be mediated by gut flora (Lehtonen et al., 1994; Lindberg, 1999; Haller and Jobin, 2004; Savino et al., 2004 Savino et al., , 2005 . Breast-fed infants have been detected for a characteristic gut microflora (Walker and Duffy, 1998; Fanaro et al., 2003; Rinne et al., 2005) as well as colicky compared to non-colicky infants (Lehtonen et al., 1994; Savino et al., 2004 Savino et al., , 2005 . Bifidobacteria and Lactobacillus seem to be predominant in breast-fed and notcolicky infants, whereas Gram-negative anaerobic bacteria seem to be predominant in the formula-fed and colicky ones. Moreover, it is very interesting that, even though Lactobacilli have a lower predominance in colicky infants, some species are characteristic of infants with colic (L. lactis lactis and L. brevis), whereas other species are characteristic of noncolicky ones (L. acidophilus). In this context, different studies reported that the addition of a high percentage of FOS/GOS to a standard infant formula determined a positive effect on Bifidobacteria and Lactobacilli growth in the intestine (Knol et al., 2002; Moro et al., 2002; Bakker-Zierikzee et al., 2005) . Modifications of intestinal flora seem to be important in the promotion of tolerance through the positive interaction on the large intestinal surface with Toll-like receptor depending signalling pathways and in the active regulation of intestinal homeostasis (Haller and Jobin, 2004; ; also clinical trials support this theory (Rigo et al., 2001; Schmelzle et al., 2003) . These changes in microflora could promote a pattern of short-chain fatty acids, increased levels of L-lactic acid and a reduction in pH, all of which resemble more closely the colonic environment of breast-fed infants (Lucas and St James-Roberts, 1998) , possibly explaining the positive results obtained after the integration of this formula in the diet of patients affected by minor feeding problems.
Our data provide compelling evidences for the relation between colic episodes reduction and kind of feeding, but in some of our cases it was not easy to determine which this link was. Infants who failed to respond to the ST with the new formula probably are those with severe infantile colic, which require a strict avoidance of cow's milk proteins (Iacono et al., 1991) . On the other hand, it should not be surprising that a number of infants of CT group -about 30% of subjects, as reported in literature (Savino et al., 2003) could have an improvement with simethicone.
The main difficulties performing this trial were both the recruitment of cases and the assessment of infants' adherence to the tested formula. Actually, a strict adherence to the inclusion criteria led the authors to exclude 45 infants who did not fulfil the criteria at the end of the trial. Moreover, all the infants have been examined on days 1, 7 and 14; on these occasions, the paediatrician could provide any explanation and information the parents needed.
A potential limitation of the evidences presented in this study is the measurement of infant distress using a number of crying episodes. We completely fulfilled Wessel's criteria to reflect infant distress: infants had to cry for more than Abbreviation: CI, confidence interval. w 2 test was used to compare the two groups by gender and family history for atopy; two-sample Student's t-test was used to compare the two groups by age at the entry and by colic episodes frequency. A value of Po0.05 was considered as statistically significant.
3 h/day on at least 3 days/week for more than 3 weeks. The use of a daily written registration of crying episodes gave more strength to the study: in fact, the reduction of the number of episodes had been associated to a defect in parent's memory when not reported on a formal registration (Canivet et al., 1996) . It should be noted that another potential limitation of the present study is the single-blinded design.
In conclusion, our study supports the hypothesis that infants fed with a partially hydrolysed formula, added with a mixture comprising 90% GOS and 10% FOS, have a significant improvement in common, but often unsolved, symptoms of the lower gastrointestinal tract, such as colic episodes.
It is probable that all the above-mentioned factors (quality of proteins, quantity of prebiotic and structure of lipids) may contribute to the positive effects of the formula we tested, but further studies could identify which one could have a prevalent action.
The study formula could represent a useful baseline approach for colic treatment in otherwise healthy infants. In case of failure, the paediatrician should better clarify the origin of the symptoms he has to deal with, in order to provide a more appropriate therapy for the patient.
However, larger studies with longer follow-up could clarify the influences of these dietary changes in clinical setting.
